Physician

Antonio Quiachon Velasco, D.O.

According to 2025 Medicare claims, Antonio Velasco, D.O. (NPI: 1053519702) practices pulmonary disease in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is INSPIRA HEALTH NETWORK MEDICAL GROUP, P.C. (NPI: 1922177856; TIN: 205745047) and primary practice location at 08360-9998. Velasco is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Velasco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 377 traditional Medicare patients, billed 1,410 HCPCS/CPT codes, and received $126,040 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 435 prescription claims across 160 beneficiaries totaling $172,892 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,232 claims. Open Payments data shows 99 records totaling $2,031. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $305,788 to $126,040. In contrast, Part D prescription costs have moved sharply higher in recent years, from $99,389 to $172,892. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $94,197 and ending at $56,096.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,461	3,785	$305,788
2016	1,418	3,790	$341,012
2017	1,328	3,327	$284,177
2018	1,186	3,534	$309,078
2019	1,170	3,696	$317,907
2020	891	2,464	$251,451
2021	910	2,330	$231,434
2022	820	1,937	$186,969
2023	736	1,814	$171,133
2024	377	1,410	$126,040

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	94	351	$99,389
2016	93	377	$87,610
2017	117	520	$117,529
2018	151	630	$206,580
2019	157	672	$211,204
2020	137	672	$214,282
2021	180	821	$351,160
2022	218	1,032	$402,050
2023	263	1,344	$571,832
2024	160	435	$172,892

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	276	1,048	$96,004
2016	364	1,293	$115,286
2017	531	1,869	$131,245
2018	525	1,930	$131,308
2019	535	1,988	$163,512
2020	549	2,100	$175,590
2021	424	1,642	$156,490
2022	462	1,533	$112,880
2023	617	2,191	$167,902
2024	434	1,232	$90,850

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	95	101	$154
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	72	72	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	110	181	$113
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	127	284	$105
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	122	195	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	91	3,150	$64,607
Nucala	Mepolizumab	12	336	$41,610
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	960	$14,365
Breo Ellipta	Fluticasone/Vilanterol	19	750	$9,719
Incruse Ellipta	Umeclidinium Bromide	20	600	$6,744

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	42	$31,622
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	16	$16,149
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	22	134	$8,552
A7031	Face mask interface, replacement for full face mask, each	N	33	77	$5,882
A7030	Full face mask used with positive airway pressure device, each	N	35	76	$5,683

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	99	$2,031	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Antonio Quiachon Velasco, D.O.?

Tedicare shows public-source Medicare data for Antonio Quiachon Velasco, D.O. (NPI 1053519702), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Antonio Quiachon Velasco, D.O. have ACO affiliation data?

Antonio Quiachon Velasco, D.O. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Antonio Quiachon Velasco, D.O.?

Antonio Quiachon Velasco, D.O. is linked to INSPIRA HEALTH NETWORK MEDICAL GROUP, P.C. (billing NPI 1922177856) in the available physician profile data.

Does Antonio Quiachon Velasco, D.O. have Open Payments data?

Antonio Quiachon Velasco, D.O. has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.